Copay Assist Programs Do Not Curb Drug Costs
Despite offering assistance to those who cannot afford medications, programs create broader problems.
Drugs
The Abuse Potential of Modafinil
In order clarify the abuse potential of modafinil, investigators characterized its psychostimulant profile by using mice.
Misuse and Abuse of Gabapentin
Researchers at ARIA Diagnostics in Indianapolis, IN conducted urine screens to test for opiates/opiods, gabapentin, pregabalin, and other substances.
Augmentation With Antidepressants in Schizophrenia Treatment Appears Safe and Efficacious
In terms of depressive and negative symptoms, in the present meta-analysis, researchers estimate that 1 in 9 patients with schizophrenia will improve with add-on antidepressants.
FDA ‘Breakthrough’ Drug Designation Can Mislead Doctors
Many believe that medications labelled “breakthrough” are supported by stronger evidence than the law requires for them to achieve that designation.
Next post in Practice Management
